City

New Haven (1)

Philadelphia (1)

San Antonio (1)

Condition

Type II; Diabetes (3)

Heart Failure (1)

Obesity (1)

Overall Status

Completed (3)

Sign in for free

Phase

n/a (1)

phase 1 (1)

phase 3 (1)

Sponsor

The University of Texas Health Science Center at San Antonio (1)

University of Pennsylvania (1)

Yale University (1)

Collaborator

Boehringer Ingelheim (1)

Intervention

collaborative social incentive (1)

competitive social incentive (1)

dapagliflozin (1)

empagliflozin (1)

placebo (1)

placebo oral capsule (1)

supportive social incentive (1)

Study Documents

Intervention Type

drug (2)

behavioral (1)

Funder Type

Other (3)

Study Type

Interventional (3)

type ii; diabetes

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Type II; Diabetes, Obesity Trial in Philadelphia (Supportive social incentive, Competitive social incentive, Collaborative

Completed

Type II; Diabetes
Obesity

Supportive social incentive
+2 more

Philadelphia, Pennsylvania

University of Pennsylvania

Sep 14, 2021

Heart Failure, Type II; Diabetes Trial in New Haven (Empagliflozin, Placebo Oral Capsule)

Completed

Heart Failure
Type II; Diabetes

Empagliflozin
Placebo Oral Capsule

New Haven, Connecticut

Yale New Haven Hospital

Jun 24, 2020

Type II; Diabetes Trial in San Antonio (Dapagliflozin, Placebo)

Completed

Has Results

Type II; Diabetes

Dapagliflozin
Placebo

San Antonio, Texas

University of Texas Health Science Center

Dec 2, 2019